HMMJ-U:CA:TSX-Horizons Marijuana Life Sciences Index ETF (USD)

ETF | Others |

Last Closing

CAD 8.36

Change

0.00 (0.00)%

Market Cap

CAD 0.09B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.29 (-1.05%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.03 (+0.06%)

CAD 4.83B
PHYS-U:CA Sprott Physical Gold Trust

+0.35 (+1.97%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.04 (-0.06%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

-0.92 (-2.24%)

CAD 3.92B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.45%)

CAD 3.78B
CEF-U:CA Sprott Physical Gold and Silve..

+0.32 (+1.47%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.14 (+0.63%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.07 (+0.33%)

CAD 2.52B

ETFs Containing HMMJ-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.60% 91% A- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.60% 91% A- 83% B
Trailing 12 Months  
Capital Gain 16.60% 66% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.60% 66% D+ 64% D
Trailing 5 Years  
Capital Gain -43.25% 2% F 12% F
Dividend Return 1.36% 65% D 7% C-
Total Return -41.88% 2% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain 15.37% 97% N/A 84% B
Dividend Return 15.41% 97% N/A 83% B
Total Return 0.04% 38% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 64.97% 2% F 12% F
Risk Adjusted Return 23.71% 61% D- 52% F
Market Capitalization 0.09B 65% D 36% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.